ENHANZE™ TECHNOLOGY LICENSE AND COLLABORATION AGREEMENT (Biologic)Confidential Treatment • September 12th, 2007 • Halozyme Therapeutics Inc • Biological products, (no disgnostic substances) • California
THIS ENHANZE TECHNOLOGY LICENSE AND COLLABORATION AGREEMENT (this “Agreement”), effective as of September 7, 2007 (the “Effective Date”) is entered into between HALOZYME, INC., a California corporation (“Halozyme”), having a place of business at 11588 Sorrento Valley Road, Suite 17, San Diego, California 92121, USA, on the one hand, and BAXTER HEALTHCARE CORPORATION, a Delaware corporation, with its principal place of business at One Baxter Parkway, Deerfield, Illinois 60015-4633, USA, and BAXTER HEALTHCARE S.A., a Swiss corporation, with its principal place of business at Hertistrasse 2, 8304 Wallisellen, Switzerland (together with its Affiliates, collectively, “Baxter”), on the other hand, with respect to the following facts:
